dihydrotestosterone has been researched along with Neurodegenerative Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sharif, S; Shoae-Hassani, A; Tabatabaei, SA; Verdi, J | 1 |
Furutani, T; Ito, S; Kato, S; Koutoku, H; Kudoh, M; Shibasaki, M; Shikama, H; Suzuki, E; Takeyama, K; Tanabe, M; Taniguchi, N | 1 |
2 other study(ies) available for dihydrotestosterone and Neurodegenerative Diseases
Article | Year |
---|---|
Could the endogenous opioid, morphine, prevent neural stem cell proliferation?
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Animals; Apoptosis; Cell Proliferation; Dihydrotestosterone; Genes, p53; Humans; Models, Biological; Morphine; Neural Stem Cells; Neurodegenerative Diseases; Rats; Regeneration; Testosterone | 2011 |
Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Animals; Animals, Genetically Modified; beta-Galactosidase; Blotting, Western; Dihydrotestosterone; Drosophila; Fluorescent Antibody Technique; Humans; Ligands; Male; Muscular Disorders, Atrophic; Mutation; Neurodegenerative Diseases; Orchiectomy; Peptides; Phenotype; Rats; Rats, Wistar; Receptors, Androgen; Structure-Activity Relationship; Transcriptional Activation | 2005 |